Assay-kits

SensoLyte® 490 HCV Protease Assay Kit Fluorimetric 500 assays - 1 kit

$663.00
Check your price
  • Cat.Number : AS-71126
  • Availability :
    In stock
  • Shipping conditions : Ice fees will apply

Select specification

Quantity

HCV protease is identified as an important drug-screening target. The SensoLyte® 490 HCV Protease Assay Kit uses an optimized FRET peptide substrate for the continuous measurement of HCV NS3/4a activity. This FRET substrate is cleaved specifically by HCV NS3/4a protease thereby liberating the C-terminal peptide-fluorophore fragment from the proximity quenching effect of the dark quencher, resulting in a more than 10-fold increase in fluorescence. This assay can detect HCV NS3/4a protease activity at 1 pmole.

Specifications

Packaging
Kits components
  • Component A: HCV NS3/4A protease substrate Ex/Em=340 nm/490 nm upon cleavage: 600 µL Component B: EDANS, fluorescence reference standard: 100 µM DMSO solution, 20 µL Component C: 2X Assay buffer: 50 mL Component D: Stop solution: 30 mL Component E: DTT: 1 M, 1 mL X 2 vials Component :F Pep4AK, HCV NS3 protease cofactor: 300 µL, 600 µM
Properties
Absorbance (nm)
  • 340
Emission (nm)
  • 490
Storage & stability
Storage Conditions
  • Store all kit components at -20°C. Protect Components A and B from light. Components C and D can be stored at room temperature for convenience.
Activity
Application
Biomarker Target
Detection Method
Detection Limit
  • 1 pmole
Research Area
Sub-category Research Area
Usage
  • Research use

You may also be interested in the following product(s)

IMG-EN-AS-25346-01.jpg

HCV NS3 Protease Inhibitor 2 - 1 mg

Cat.Number : AS-25346
$431.00
IMG-EN-AS-60798-01.jpg

HCV NS3/4A Protease Substrate - 1 mg

Cat.Number : AS-60798
$733.00
IMG-EN-AS-22991-01.jpg

HCV Protease FRET Substrate (RET S1)

Cat.Number : AS-22991
$595.00

Citations

Failure of pelvic organ support in mice deficient in fibulin-3

Am J Pathol . 2008 Dec 18 ; 174 206 | DOI : 10.2353/ajpath.2009.080212

  • D. Rahn
  • et al

IL-1β-induced, matrix metalloproteinase-3-regulated proliferation of embryonic stem cell-derived odontoblastic cells is mediated by the Wnt5 signaling pathway

Exp Cell Res . 2014 May 20 ; 328(1) 69 | DOI : 10.1016/j.yexcr.2014.05.006

  • N. Ozeki
  • et al

Endothelins stimulate the production of stromelysin-1 in cultured rat astrocytes

Biochem Biophys Res Commun . 2008 Apr 03 ; 371(4) 659 | DOI : 10.1016/j.bbrc.2008.04.064

  • Y. Koyama
  • et al

Impaired dephosphorylation renders G6PD-knockdown HepG2 cells more susceptible to H(2)O(2)-induced apoptosis.

Free Radic Biol Med . 2010 Apr 24 ; 361 49(3) | DOI : 10.1016/j.freeradbiomed.2010.04.019

  • C. Lin
  • et al

2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity.

Bioorg Med Chem Lett . 2011 Jun 01 ; 21(11) 3202 | DOI : 10.1016/j.bmcl.2011.04.055

  • H.R. Park
  • et al

Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase.

J Infect Dis. . 2011 Aug 15 ; 204(4) 609 | DOI : 10.1093/infdis/jir303

  • L.F. Peng
  • et al

Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.

Antiviral Res . 2011 Sep 01 ; 91(3) 233 | DOI : 10.1016/j.antiviral.2011.05.017

  • C. Yon
  • et al

A method to simultaneously monitor hepatitis C virus NS3 helicase and protease activities.

Methods Mol Biol . 2010 Jan 01 ; 587 223 | DOI : 10.1007/978-1-60327-355-8_16

  • D.N. Frick
  • et al

Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells.

Exp Cell Res . 2009 Oct 21 ; 316(3) 366 | DOI : 10.1016/j.yexcr.2009.10.011

  • V. Lopez
  • et al